4/A//SEC Filing
Bender James G. 4/A
Accession 0001181431-13-011843
CIK 0000822411other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 3:59 PM ET
Size
7.8 KB
Accession
0001181431-13-011843
Insider Transaction Report
Form 4/AAmended
Bender James G.
VP, Product Development & Mfg.
Transactions
- Sale
Common Stock
2012-06-01$3.60/sh−4,900$17,640→ 1,279 total - Sale
Common Stock
2012-06-01$3.61/sh−600$2,166→ 679 total - Sale
Common Stock
2012-06-01$3.59/sh−1,500$5,385→ 6,179 total
Footnotes (1)
- [F1]This Form 4 is being amended to correct a calculation error in the Amount of Securities Beneficially Owned Following Reported Transactions.
Documents
Issuer
ImmunoCellular Therapeutics, Ltd.
CIK 0000822411
Entity typeother
Related Parties
1- filerCIK 0001550455
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 3:59 PM ET
- Size
- 7.8 KB